Companies › DCOY

DECOY THERAPEUTICS INC COM (DCOY)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001615219 · EDGAR filings · Updated 2026-07-24

DECOY THERAPEUTICS INC COM (DCOY) has reported institutional ownership of 0.3%, with 4 institutional managers holding positions valued at $10.5K per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-24 — PRE 14A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — EFFECT filed
• 2026-07-17 — Prospectus supplement (424B3) filed
• 2026-07-15 — Current report (8-K) filed
• 2026-07-10 — Registration statement (S-1) filed
• 2026-06-29 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, DECOY THERAPEUTICS INC COM has 4 institutional holders and institutional ownership of 0.3%.

Insider activity

Insiders reported 4 transactions (2 buys, 2 sells) across 3 reporting insiders, with a net reported value of $19.7K.

Data flags from SEC filings

Related companies

BIOTRICITY INC (BTCY) · SYNLOGIC INC (SYBX) · SciSparc Ltd (SPRC) · IM CANNABIS CORP (IMCC) · AYR Wellness Inc. (AYRWF) · United Health Prods Inc COM (UEEC)